By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Lumexa Imaging Holdings, Inc. Common Stock

Lumexa Imaging Holdings, Inc. Common Stock (LMRI)

NASDAQ Market Data in USD
$268.00
+$4.48
+1.70%
Last Update: 18 Jul 2026, 03:20
$0.00
Market Cap
P/E Ratio (TTM)
Forward Dividend Yield
$180.62-$344.29
52 Week Range

LMRI Stock Price Chart

Explore Lumexa Imaging Holdings, Inc. Common Stock interactive price chart. Choose custom timeframes to analyze LMRI price movements and trends.

LMRI Company Profile

Discover essential business fundamentals and corporate details for Lumexa Imaging Holdings, Inc. Common Stock (LMRI) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

11 Dec 2025

Employees

CEO

Caitlin Zulla

Description

Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.

LMRI Financial Timeline

Browse a chronological timeline of Lumexa Imaging Holdings, Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 11 Aug 2026

EPS estimate is $0.17, while revenue estimate is $263.23m.

Earnings released on 3 Jun 2026

Earnings released on 12 May 2026

EPS came in at $0.18 surpassing the estimated $0.12 by +50.00%, while revenue for the quarter reached $252.54m , beating expectations by +1.21%.

Earnings released on 26 Mar 2026

EPS came in at -$0.66 falling short of the estimated $0.05 by -1.42k%, while revenue for the quarter reached $267.73m , beating expectations by +2.51%.

Earnings released on 3 Dec 2025

EPS came in at -$0.03 , while revenue for the quarter reached $260.08m .

LMRI Stock Performance

Access detailed LMRI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run